Lead party: Microtraction (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: 54Gene, Inc. (private company) · Sector: Healthcare, Biotechnology · Countries of operation: Nigeria
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Pre-Seed · Deal amount: US$15,000 · Equity stake: 0.075% · Implied EV: US$200,000
Lead investor/buyer: Microtraction · Investors/buyers: Microtraction
Legal advisers: not identified in the source record.
Source: announced 20 March 2019. Original announcement: techcrunch.com.


